Cite
HARVARD Citation
Shilova, I. et al. (n.d.). DOP54 Identification and development of a 1st in class naturally-derived protein that drives mucosal healing and is orally delivered by an engineered cellular therapy targeting the gastro-intestinal tract. Journal of Crohn's and colitis. p. i102. [Online].